These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11577585)

  • 1. [Allorecognition].
    Lebranchu Y
    Presse Med; 2001 Sep; 30(24 Pt 2):31-4. PubMed ID: 11577585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerogenic response: allorecognition pathways.
    Caballero A; Fernandez N; Lavado R; Bravo MJ; Miranda JM; Alonso A
    Transpl Immunol; 2006 Dec; 17(1):3-6. PubMed ID: 17157204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy.
    Wang Z; Shufesky WJ; Montecalvo A; Divito SJ; Larregina AT; Morelli AE
    PLoS One; 2009; 4(3):e4940. PubMed ID: 19333400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and indirect antigen recognition: the pathways to allograft immune rejection.
    Benichou G
    Front Biosci; 1999 May; 4():D476-80. PubMed ID: 10331992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How T cells recognize alloantigen: evidence for two pathways of allorecognition.
    Watschinger B
    Nephrol Dial Transplant; 1995; 10(9):1556-8. PubMed ID: 8559468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune recognition and rejection of allogeneic skin grafts.
    Benichou G; Yamada Y; Yun SH; Lin C; Fray M; Tocco G
    Immunotherapy; 2011 Jun; 3(6):757-70. PubMed ID: 21668313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alloimmune response and effector mechanisms of allograft rejection.
    Arakelov A; Lakkis FG
    Semin Nephrol; 2000 Mar; 20(2):95-102. PubMed ID: 10746853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.
    Duncan MD; Wilkes DS
    Proc Am Thorac Soc; 2005; 2(5):449-55. PubMed ID: 16322599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance.
    Jiang S; Herrera O; Lechler RI
    Curr Opin Immunol; 2004 Oct; 16(5):550-7. PubMed ID: 15341998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelial cells in allograft rejection.
    Rose ML
    Vasc Med; 1997; 2(2):105-14. PubMed ID: 9546952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of allogenic recognition in transplantation systems].
    Fedoseeva EV
    Biokhimiia; 1995 Feb; 60(2):238-49. PubMed ID: 7718667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD47 is required for suppression of allograft rejection by donor-specific transfusion.
    Wang H; Wu X; Wang Y; Oldenborg PA; Yang YG
    J Immunol; 2010 Apr; 184(7):3401-7. PubMed ID: 20208011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiology of rejection and adaptation.
    Trivedi HL
    Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
    Liu Z; Colovai AI; Tugulea S; Reed EF; Fisher PE; Mancini D; Rose EA; Cortesini R; Michler RE; Suciu-Foca N
    J Clin Invest; 1996 Sep; 98(5):1150-7. PubMed ID: 8787678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection mechanisms in transplantation.
    Game DS; Warrens AN; Lechler RI
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):832-8. PubMed ID: 11732119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles in allograft rejection and tolerance.
    Benichou G; Wang M; Ahrens K; Madsen JC
    Cell Immunol; 2020 Mar; 349():104063. PubMed ID: 32087929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.